What is the brand name of dextroamphetamine-amphetamine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brand Name of Dextroamphetamine-Amphetamine

The brand name for dextroamphetamine-amphetamine mixed salts is Adderall, with the extended-release formulation marketed as Adderall XR. 1, 2

Available Formulations

  • Immediate-release formulation: Marketed as Adderall, containing a 3:1 ratio of dextroamphetamine to levoamphetamine salts 2

  • Extended-release formulation: Marketed as Adderall XR, which uses a dual-release mechanism with immediate-release pellets that deliver half the dose upon ingestion and delayed-release pellets that release the remaining dose approximately 4 hours later 2

Important Distinction

Note that dextroamphetamine alone (without the mixed amphetamine salts) is marketed under different brand names, specifically Dexedrine and ProCentra, which are single-entity dextroamphetamine products rather than the mixed amphetamine salt combination 3. These are distinct medications from Adderall, which contains both dextroamphetamine and levoamphetamine in combination.

Clinical Characteristics

  • Adderall XR provides approximately 12 hours of symptom coverage with onset of action within 1.5 hours 2

  • The usual starting dose for adults is 10 mg once daily in the morning, with titration in 5 mg weekly increments up to a maximum of 50 mg daily 1, 4

  • Both formulations are DEA Schedule II controlled substances due to high potential for abuse 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dextroamphetamine Brand Names and Formulations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Concurrent Use of Adderall and Progesterone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adderall® (amphetamine-dextroamphetamine) toxicity.

Topics in companion animal medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.